Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.

Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.

Gene expression profiling studies have reported up-regulated mRNA expression of the FOXP1 forkhead transcription factor in response to normal B-cell activation and high expression in a poor prognosis subtype of diffuse large B-cell lymphoma (DLBCL). The purpose of this study was to investigate the p...

Full description

Bibliographic Details
Main Authors:	Banham, A, Connors, J, Brown, P, Cordell, J, Ott, G, Sreenivasan, G, Farinha, P, Horsman, D, Gascoyne, R
Format:	Journal article
Language:	English
Published:	2005

Similar Items

The significance of FOXP1 in diffuse large B-cell lymphoma
by: Gascoyne, D, et al.
Published: (2016)

The architectural pattern of FOXP3(+) T cells is an independent predictor of survival in patients with follicular lymphoma (FL)
by: Farinha, P, et al.
Published: (2006)

The architectural pattern of FOXP3*T cells is an independent predictor of survival in patients with follicular lymphoma (FL)
by: Farinha, P, et al.
Published: (2006)

Identification of FOXP1 Transcriptional Targets in Diffuse Large B Cell Lymphoma
by: Camilleri, E, et al.
Published: (2012)

The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma.
by: Brown, P, et al.
Published: (2005)

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome.
by: Barrans, S, et al.
Published: (2004)

Strong expression of FOXP1 predicts for poor prognosis within the non-germinal centre subgroup of diffuse large B cell lymphoma
by: Barrans, S, et al.
Published: (2005)

Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation.
by: Haralambieva, E, et al.
Published: (2006)

Is FOXP3 expressed in cutaneous T-cell lymphomas?
by: Banham, A, et al.
Published: (2008)

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures
by: Wong, K, et al.
Published: (2016)

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
by: Hans, C, et al.
Published: (2004)

FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas
by: Brown, P, et al.
Published: (2015)

FOXP3 expression in B and T cell lymphomas.
by: Roncador, G, et al.
Published: (2005)

FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control.
by: Goatly, A, et al.
Published: (2008)

FOXP1 abnormalities in lymphoma: Translocation breakpoint mapping reveals insights into deregulated transcriptional control
by: Goatly, A, et al.
Published: (2008)

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients
by: Wong, K, et al.
Published: (2014)

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.
by: Wong, K, et al.
Published: (2014)

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
by: Nyman, H, et al.
Published: (2009)

BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas
by: Nyman, H, et al.
Published: (2008)

CRISPR/Cas9-mediated Foxp1 silencing restores immune surveillance in an immunocompetent A20 lymphoma model
by: Felce, SL, et al.
Published: (2020)

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.
by: Carreras, J, et al.
Published: (2006)

t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma.
by: Fenton, J, et al.
Published: (2006)

Deregulated over expression of FOXP1 protein in diffuse large B-cell lymphoma does not occur as a result of gene rearrangement.
by: Barrans, S, et al.
Published: (2007)

The FOXP3 transcription factor as a regulatory T-cell marker
by: Banham, A
Published: (2008)

FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma.
by: Roncador, G, et al.
Published: (2005)

Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas.
by: Fox, S, et al.
Published: (2004)

MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
by: Borovecki, A, et al.
Published: (2007)

Pathway activation patterns in diffuse large B-cell lymphomas.
by: Bentink, S, et al.
Published: (2008)

Translocations involving IGH gene predict better survival in gastric diffuse large B-cell lymphoma
by: Ye, H, et al.
Published: (2008)

Translocations involving IGH gene predict better survival in gastric diffuse large B-cell lymphoma
by: Ye, H, et al.
Published: (2008)

Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers.
by: Rayoo, M, et al.
Published: (2009)

TRPM4 expression is associated with activated B-cell subtype and poor survival in diffuse large B-cell lymphoma
by: Loo, S, et al.
Published: (2017)

Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma.
by: Lawrie, C, et al.
Published: (2009)

Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells.
by: Campbell, A, et al.
Published: (2010)

Serologic detection of diffuse large B-cell lymphoma-associated antigens.
by: Liggins, A, et al.
Published: (2004)

Conserved oncogenic module activation patterns (COMAPS) identify biologically homogeneous groups of diffuse large B-cell lymphomas and clearly define Burkitt lymphoma
by: Bentink, S, et al.
Published: (2008)

The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p.
by: Banham, A, et al.
Published: (2001)

N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells.
by: Brown, P, et al.
Published: (2016)

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
by: Choi, W, et al.
Published: (2009)

Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma.
by: Nakamura, S, et al.
Published: (2008)